SG160352A1 - Process for the purification of substituted benzoxazole compounds - Google Patents

Process for the purification of substituted benzoxazole compounds

Info

Publication number
SG160352A1
SG160352A1 SG201001457-9A SG2010014579A SG160352A1 SG 160352 A1 SG160352 A1 SG 160352A1 SG 2010014579 A SG2010014579 A SG 2010014579A SG 160352 A1 SG160352 A1 SG 160352A1
Authority
SG
Singapore
Prior art keywords
purification
benzoxazole compounds
substituted benzoxazole
compound
solution
Prior art date
Application number
SG201001457-9A
Other languages
English (en)
Inventor
Silvio Iera
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of SG160352A1 publication Critical patent/SG160352A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG201001457-9A 2005-03-07 2006-03-06 Process for the purification of substituted benzoxazole compounds SG160352A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65921205P 2005-03-07 2005-03-07

Publications (1)

Publication Number Publication Date
SG160352A1 true SG160352A1 (en) 2010-04-29

Family

ID=36579426

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201001457-9A SG160352A1 (en) 2005-03-07 2006-03-06 Process for the purification of substituted benzoxazole compounds

Country Status (20)

Country Link
US (1) US7579478B2 (de)
EP (1) EP1856068A1 (de)
JP (1) JP2008531748A (de)
KR (1) KR20070111515A (de)
CN (1) CN101128443A (de)
AR (1) AR052934A1 (de)
AU (1) AU2006220680A1 (de)
BR (1) BRPI0607816A2 (de)
CA (1) CA2601975A1 (de)
GT (1) GT200600104A (de)
IL (1) IL185146A0 (de)
MX (1) MX2007010895A (de)
NI (1) NI200700206A (de)
NO (1) NO20074103L (de)
PA (1) PA8665701A1 (de)
PE (1) PE20061181A1 (de)
RU (1) RU2007130408A (de)
SG (1) SG160352A1 (de)
TW (1) TW200643017A (de)
WO (1) WO2006096624A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080146630A1 (en) * 2006-11-21 2008-06-19 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
US20080139633A1 (en) * 2006-11-21 2008-06-12 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
US20080132554A1 (en) * 2006-11-21 2008-06-05 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
US20080176914A1 (en) * 2006-11-21 2008-07-24 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
WO2006096584A1 (en) * 2005-03-07 2006-09-14 Wyeth Process for the preparation of substituted benzoxazole compounds

Also Published As

Publication number Publication date
US7579478B2 (en) 2009-08-25
TW200643017A (en) 2006-12-16
KR20070111515A (ko) 2007-11-21
MX2007010895A (es) 2007-12-05
IL185146A0 (en) 2007-12-03
NI200700206A (es) 2008-07-03
PA8665701A1 (es) 2007-01-17
BRPI0607816A2 (pt) 2010-03-23
AR052934A1 (es) 2007-04-11
CN101128443A (zh) 2008-02-20
PE20061181A1 (es) 2006-12-19
EP1856068A1 (de) 2007-11-21
CA2601975A1 (en) 2006-09-14
AU2006220680A1 (en) 2006-09-14
WO2006096624A1 (en) 2006-09-14
US20060199967A1 (en) 2006-09-07
GT200600104A (es) 2006-10-25
RU2007130408A (ru) 2009-04-20
NO20074103L (no) 2007-12-05
JP2008531748A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
WO2009004427A3 (en) Benzimidazole derivatives
BR112021020637A2 (pt) Derivados de tetra-hidro-1h-ciclopenta[cd]indeno como inibidores de fator -2(alfa) induzível por hipóxia
WO2008055870A8 (en) Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008034859A8 (en) Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2007031548A3 (en) Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
IN2015DN02325A (de)
RS20060097A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
BRPI0610644B8 (pt) composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
TW200510333A (en) Benzimidazole compounds
SG160352A1 (en) Process for the purification of substituted benzoxazole compounds
CY1115119T1 (el) Αναστολεις μεταφορεα γλυκινης-1
EP1831239B8 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carbonsäure gamma-lacton und schlüsselzwischenprodukte für dieses verfahren
MX2009002998A (es) Derivado de pirazolopirimidina.
WO2009040314A3 (de) Neue heteroarylsubstituierte acetonderivate, geeignet zur hemmung der phospholipase a2
PT1745010E (pt) Derivados de ciclo-hexil-1,4-diamina substituídos
WO2010081835A3 (en) Bis-resorcinyl-triazine derivatives as protecting agents against uv radiation
NO20076000L (no) Aminosyrederivater
BRPI0403028A (pt) Compostos heterocìclicos de oxima, processo para sua preparação e composições farmacêuticas contendo os mesmos
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
WO2007057767A3 (en) Amino acid derivatives
TW200716521A (en) Substituted aryl oximes
UA94615C2 (uk) Інгібітори транспортера-1 гліцину